Sökning: WFRF:(Janefjord Camilla) >
A protective role o...
A protective role of lysozyme in Alzheimer disease
-
- Helmfors, Linda (författare)
- Linköpings universitet,Institutionen för fysik, kemi och biologi,Tekniska högskolan
-
- Armstrong, Andrea (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Hälsouniversitetet
-
- Civitelli, Livia (författare)
- Linköpings universitet,Institutionen för klinisk och experimentell medicin,Hälsouniversitetet
-
visa fler...
-
- Sandin, Linnea (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Hälsouniversitetet
-
- Nath, Sangeeta (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Hälsouniversitetet
-
- Janefjord, Camilla (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Hälsouniversitetet
-
- Zetterberg, Henrik (författare)
- Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden
-
- Blennow, Kaj (författare)
- Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden
-
- Garner, Brett (författare)
- Illawarra Health and Medical Research Institute University of Wollongong, Australia
-
- Brorsson, Ann-Christin (författare)
- Linköpings universitet,Kemi,Tekniska högskolan
-
- Kågedal, Katarina (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Hälsouniversitetet
-
visa färre...
-
(creator_code:org_t)
- Engelska.
- Relaterad länk:
-
https://urn.kb.se/re...
Abstract
Ämnesord
Stäng
- Alzheimer disease (AD) is a devastating neurodegenerative disorder where extracellular plaques composed of amyloid β (Aβ) peptides and neuroinflammation are some of the main hallmarks of the disease. Activated microglial cells, which are the resident macrophages in the central nervous system, are suggested to trigger the inflammation response in AD. To discover neuroinflammation biomarkers would be important to reveal the pathological mechanisms of AD and develop therapies that target inflammation mediators. Lysozyme is part of the innate immune system and is secreted from macrophages during various inflammation conditions. However, the involvement of lysozyme in AD pathology has not been explored previously. We have discovered that lysozyme is up-regulated in cerebrospinal fluid from AD patients. Cells exposed to Aβ increased the expression of lysozyme indicating that Aβ might be responsible for the upregulation of lysozyme detected in cerebrospinal fluid. In vitro studies revealed that lysozyme binds to monomeric Aβ1-42 and alters the aggregation pathway counteracting formation of toxic Aβ species. In a newly developed Drosophila model, co-expression of lysozyme with Aβ in brain neurons reduced the formation of insoluble Aβ species, prolonged the survival and improved the activity of the double transgenic flies compared to flies only expressing Aβ. Our findings identify lysozyme as a modulator of Aβ aggregation and toxicity and our discoveries has the potential to be used for development of new treatment strategies and to use lysozyme as a biomarker for AD.
Nyckelord
- Lysozyme
- Biomarker
- Alzheimer disease
- Drosophila
- CSF
- Aβ aggregation
Publikations- och innehållstyp
- vet (ämneskategori)
- ovr (ämneskategori)
- Av författaren/redakt...
-
Helmfors, Linda
-
Armstrong, Andre ...
-
Civitelli, Livia
-
Sandin, Linnea
-
Nath, Sangeeta
-
Janefjord, Camil ...
-
visa fler...
-
Zetterberg, Henr ...
-
Blennow, Kaj
-
Garner, Brett
-
Brorsson, Ann-Ch ...
-
Kågedal, Katarin ...
-
visa färre...
- Av lärosätet
-
Linköpings universitet